Microbix Biosystems Inc (TSX:MBX)
C$ 0.345 -0.015 (-4.17%) Market Cap: 47.16 Mil Enterprise Value: 40.71 Mil PE Ratio: 9.09 PB Ratio: 1.69 GF Score: 66/100

Microbix Biosystems Inc at Adelaide Capital Virtual COVID & Healthcare Mini Conference Transcript

Apr 23, 2020 / NTS GMT
Release Date Price: C$0.32
Cameron Groome
Microbix Biosystems Inc. - CEO, President & Director

Microbix, of course, is a specialist in infectious diseases. Our company started providing growth media to public health laboratories culturing different bacterial and viral strains circulating into the community. We then over the years moved to actually growing the organisms for the public health labs. And then some years ago, we're invited to actually provide those products to global manufacturers of immunoassays and diagnostic tests.

So we're actually a global leader, if not the global leader in [provassay] or so-called serology tests. And we actually provide a whole series of those products. You can see here all the organisms that we culture at industrial scale -- culture, purify, and inactivate in industrial scale in our facilities in this (technical difficulty)

So it's a very important company from a global public health perspective. What we do and we have actually [a mit] full of letters recently attesting to our being essential to public health on a global basis. That is about 90% of our current sales is two

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot